Tuberculosis Drug Market Size By Application, Industry Analysis Report, Regional Outlook (North America, Europe, Asia Pacific, Middle East & Africa And South America), Growth Potential, Price Trends, Competitive Market Share & Forecast 2023 - 2030 (Recession Impact Analysis)
ID : MRU_
53914 | Date :
Jan, 2023 | Pages :
168 | Region : Global |
Publisher : Ri
Tuberculosis (TB) is an infectious disease, which is caused by Mycobacterium tuberculosis. These bacteria generally infect human lungs. However, it can infect other body parts/organs as well. Three major types of tuberculosis are found: latent, active, and drug-resistant tuberculosis. Symptoms are not identifiable in case of latent tuberculosis, due to presence of an inactive form of bacteria. In active tuberculosis, symptoms are clearly visible and they can spread from one person to another. Coughing for more than two weeks, chest pain, coughing up blood, chills, fatigue, unintentional weight loss, fever, and loss of appetite are some of the common symptoms of active tuberculosis. HIV/AIDS, severe kidney disease, cancer, diabetes, and malnutrition are some of the key risk factors generally found to be associated with tuberculosis.
Growing prevalence of multi-drug resistant tuberculosis is driving the tuberculosis drugs market. Drug shortages is a major restraint for the tuberculosis drugs market, especially in low- to medium-income countries of the world. Tuberculosis associated with diseases such as HIV/AIDS and conditions such as obesity is extremely difficult to manage. The tuberculosis drugs market can be segmented based on drug class, disease type, end-user, and region. In terms of drug class, the market can be categorized into first-line therapy, second-line therapy, and combination therapy. Isoniazid, Pyrazinamide, Rifampin, and Ethambutol majorly constitute the first-line therapy for TB; while Streptomycin, Capreomycin, Ethionamide, Levofloxacin, and Gatifloxacin are generally considered as a part of the second-line therapy. Second-line therapy is expected to be a rapidly growing segment of the tuberculosis drugs market.
The Global Tuberculosis Drug Market had reached xxx million USD with a CAGR xx from 2018-2022. Later on, it will go to xxx million USD in 2023 with a CAGR xx % from 2023-2030.
In the global Tuberculosis Drug Market, This report focuses particularly in North America, South America, Europe and Asia-Pacific, and Middle East and Africa. This report classifies the Market on the basis of application, type, regions, and manufactures.
In Market segmentation by manufacturers, the report covers the following companies-
Lupin
Otsuka Novel Products
Pfizer
Sanofi
In Market segmentation by geographical regions, the report has analysed the following regions-
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
In Market segmentation by types :
First-line Anti-TB Drugs
Second-line Anti-TB Drugs
In Market segmentation by applications :
Active TB
Latent TB
The research provides answers to the following key questions:
• What is the estimated growth rate and Market share and size of the Tuberculosis Drug Market for the forecast period 2023-2030?
• What are the driving forces in the Tuberculosis Drug Market for the forecast period 2023-2030?
• Who are the prominent Market players and how have they gained a competitive edge over other competitors?
• What are the Market trends influencing the progress of the Tuberculosis Drug industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the Market hold for the prominent Market players? Any special requirements about this report, please let us know and we can provide custom report.
Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Tuberculosis Drug Market Size Growth Rate by Type (2020-2030)
1.3.2 First-line Anti-TB Drugs
1.3.3 Second-line Anti-TB Drugs
1.4 Market Segment by Application
1.4.1 Global Tuberculosis Drug Market Share by Application (2020-2030)
1.4.2 Active TB
1.4.3 Latent TB
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tuberculosis Drug Market Size
2.1.1 Global Tuberculosis Drug Revenue 2015-2030
2.1.2 Global Tuberculosis Drug Sales 2015-2030
2.2 Tuberculosis Drug Growth Rate by Regions
2.2.1 Global Tuberculosis Drug Sales by Regions 2015-2020
2.2.2 Global Tuberculosis Drug Revenue by Regions 2015-2020
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Tuberculosis Drug Sales by Manufacturers
3.1.1 Tuberculosis Drug Sales by Manufacturers 2015-2020
3.1.2 Tuberculosis Drug Sales Market Share by Manufacturers 2015-2020
3.2 Revenue by Manufacturers
3.2.1 Tuberculosis Drug Revenue by Manufacturers (2018-2022)
3.2.2 Tuberculosis Drug Revenue Share by Manufacturers (2018-2022)
3.2.3 Global Tuberculosis Drug Market Concentration Ratio (CR5 and HHI)
3.3 Tuberculosis Drug Price by Manufacturers
3.4 Key Manufacturers Tuberculosis Drug Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Tuberculosis Drug Market
3.6 Key Manufacturers Tuberculosis Drug Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 First-line Anti-TB Drugs Sales and Revenue (2018-2022)
4.1.2 Second-line Anti-TB Drugs Sales and Revenue (2018-2022)
4.2 Global Tuberculosis Drug Sales Market Share by Type
4.3 Global Tuberculosis Drug Revenue Market Share by Type
4.4 Tuberculosis Drug Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Tuberculosis Drug Sales by Application
6 United States
6.1 United States Tuberculosis Drug Breakdown Data by Company
6.2 United States Tuberculosis Drug Breakdown Data by Type
6.3 United States Tuberculosis Drug Breakdown Data by Application
7 European Union
7.1 European Union Tuberculosis Drug Breakdown Data by Company
7.2 European Union Tuberculosis Drug Breakdown Data by Type
7.3 European Union Tuberculosis Drug Breakdown Data by Application
8 China
8.1 China Tuberculosis Drug Breakdown Data by Company
8.2 China Tuberculosis Drug Breakdown Data by Type
8.3 China Tuberculosis Drug Breakdown Data by Application
9 Rest of World
9.1 Rest of World Tuberculosis Drug Breakdown Data by Company
9.2 Rest of World Tuberculosis Drug Breakdown Data by Type
9.3 Rest of World Tuberculosis Drug Breakdown Data by Application
9.4 Rest of World Tuberculosis Drug Breakdown Data by Countries
9.4.1 Rest of World Tuberculosis Drug Sales by Countries
9.4.2 Rest of World Tuberculosis Drug Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Lupin
10.1.1 Lupin Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Tuberculosis Drug
10.1.4 Tuberculosis Drug Product Introduction
10.1.5 Lupin Recent Development
10.2 Otsuka Novel Products
10.2.1 Otsuka Novel Products Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Tuberculosis Drug
10.2.4 Tuberculosis Drug Product Introduction
10.2.5 Otsuka Novel Products Recent Development
10.3 Pfizer
10.3.1 Pfizer Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Tuberculosis Drug
10.3.4 Tuberculosis Drug Product Introduction
10.3.5 Pfizer Recent Development
10.4 Sanofi
10.4.1 Sanofi Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Tuberculosis Drug
10.4.4 Tuberculosis Drug Product Introduction
10.4.5 Sanofi Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Tuberculosis Drug Sales Channels
11.2.2 Tuberculosis Drug Distributors
11.3 Tuberculosis Drug Customers
12 Market Forecast
12.1 Global Tuberculosis Drug Sales and Revenue Forecast 2020-2030
12.2 Global Tuberculosis Drug Sales Forecast by Type
12.3 Global Tuberculosis Drug Sales Forecast by Application
12.4 Tuberculosis Drug Forecast by Regions
12.4.1 Global Tuberculosis Drug Sales Forecast by Regions 2020-2030
12.4.2 Global Tuberculosis Drug Revenue Forecast by Regions 2020-2030
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
Research Methodology
The Market Research Update offers technology-driven solutions and its full integration in the research process to be skilled at every step. We use diverse assets to produce the best results for our clients. The success of a research project is completely reliant on the research process adopted by the company. Market Research Update assists its clients to recognize opportunities by examining the global market and offering economic insights. We are proud of our extensive coverage that encompasses the understanding of numerous major industry domains.
Market Research Update provide consistency in our research report, also we provide on the part of the analysis of forecast across a gamut of coverage geographies and coverage. The research teams carry out primary and secondary research to implement and design the data collection procedure. The research team then analyzes data about the latest trends and major issues in reference to each industry and country. This helps to determine the anticipated market-related procedures in the future. The company offers technology-driven solutions and its full incorporation in the research method to be skilled at each step.
The Company's Research Process Has the Following Advantages:
Information Procurement
The step comprises the procurement of market-related information or data via different methodologies & sources.
Information Investigation
This step comprises the mapping and investigation of all the information procured from the earlier step. It also includes the analysis of data differences observed across numerous data sources.
Highly Authentic Source
We offer highly authentic information from numerous sources. To fulfills the client’s requirement.
Market Formulation
This step entails the placement of data points at suitable market spaces in an effort to assume possible conclusions. Analyst viewpoint and subject matter specialist based examining the form of market sizing also plays an essential role in this step.
Validation & Publishing of Information
Validation is a significant step in the procedure. Validation via an intricately designed procedure assists us to conclude data-points to be used for final calculations.
We are flexible and responsive startup research firm. We adapt as your research requires change, with cost-effectiveness and highly researched report that larger companies can't match.
Information Safety
Market Research Update ensure that we deliver best reports. We care about the confidential and personal information quality, safety, of reports. We use Authorize secure payment process.
We Are Committed to Quality and Deadlines
We offer quality of reports within deadlines. We've worked hard to find the best ways to offer our customers results-oriented and process driven consulting services.
Our Remarkable Track Record
We concentrate on developing lasting and strong client relationship. At present, we hold numerous preferred relationships with industry leading firms that have relied on us constantly for their research requirements.
Best Service Assured
Buy reports from our executives that best suits your need and helps you stay ahead of the competition.
Customized Research Reports
Our research services are custom-made especially to you and your firm in order to discover practical growth recommendations and strategies. We don't stick to a one size fits all strategy. We appreciate that your business has particular research necessities.
Service Assurance
At Market Research Update, we are dedicated to offer the best probable recommendations and service to all our clients. You will be able to speak to experienced analyst who will be aware of your research requirements precisely.